Amgen To Present At The Morgan Stanley Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- Tesla profit disappoints, EV maker posts cash burn as AI spending surges
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Crude Inventory Rose 2 Million Barrels Last Week - EIA
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
September 9, 2019 7:03 AM EDTCantor Fitzgerald analyst Alethia Young reiterated a Neutral rating and $230.00 price target on Amgen (NASDAQ: AMGN) after the company presented updated AMG-510 data at the World Lung medical meeting and hosted a conference call to discuss the data. This update included an additional... More
